Boston Scientific (BSX) EBT Margin (2009 - 2026)
Boston Scientific's (BSX) quarterly EBT Margin came in at 19.48% in Q2 2026, up 88.0% year-over-year from 10.36% in Q2 2025, and down 12.78% quarter-over-quarter from 22.33% in Q1 2026.
Analysis
Boston Scientific (BSX) EBT Margin (2009 - 2026) Analysis & Trends
Boston Scientific has disclosed EBT Margin across 18 years of filings, most recently posting 19.48% for Q2 2026.
- In Q2 2026, EBT Margin rose 88.0% year-over-year to 19.48%; the TTM figure through Jun 2026 stood at 18.39% (up 217.0% YoY), while the FY2025 annual figure was 16.86%, up 324.0% from the prior year.
- EBT Margin came in at 19.48% for Q2 2026 at Boston Scientific, down from 22.33% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 22.33% in Q1 2026 to a low of 5.16% in Q1 2022.
- Average EBT Margin over 5 years is 14.2%, with a median of 13.4% recorded in 2023.
- Year-over-year, EBT Margin plunged 874 bps in 2022 and soared 957 bps in 2023.
- Over 5 years, EBT Margin stood at 12.21% in 2022, then increased by 11 bps to 13.56% in 2023, then fell by 5 bps to 12.83% in 2024, then advanced by 3 bps to 13.24% in 2025, then soared by 47 bps to 19.48% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 19.48% in Q2 2026, 22.33% in Q1 2026, and 13.24% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 11.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.48% |
| Mar 31, 2026 | 22.33% |
| Dec 31, 2025 | 13.24% |
| Sep 30, 2025 | 18.54% |
| Jun 30, 2025 | 18.59% |
| Mar 31, 2025 | 17.26% |
| Dec 31, 2024 | 12.83% |
| Sep 30, 2024 | 15.89% |
| Jun 30, 2024 | 10.19% |
| Mar 31, 2024 | 15.77% |
| Dec 31, 2023 | 13.56% |
| Sep 30, 2023 | 17.30% |
| Jun 30, 2023 | 11.84% |
| Mar 31, 2023 | 13.10% |
| Dec 31, 2022 | 12.21% |
| Sep 30, 2022 | 7.73% |
| Jun 30, 2022 | 10.64% |
| Mar 31, 2022 | 5.16% |
| Dec 31, 2021 | 3.81% |
| Sep 30, 2021 | 16.47% |